Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity

v3.22.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings (deficit)
Retained earnings (deficit)
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interests
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance (in shares) at Dec. 31, 2018       1,000 32,556,303 32,557,303              
Beginning balance at Dec. 31, 2018 $ 545,156 $ 0 $ 545,156 $ 0 $ 3 $ 3 $ 508,823 $ (3) $ 508,820 $ 23,762 $ 23,762 $ 12,571 $ 12,571
Increase (Decrease) in Shareholders' Equity                          
Contributions from noncontrolling interests 130                     130  
Net transfers to parent 15,693           15,693            
Net (loss) income of unconsolidated joint ventures 22,391                 17,200   5,191  
Ending Balance (in shares) at Dec. 31, 2019       32,557,303                  
Ending balance at Dec. 31, 2019 583,370     $ 3     524,513     40,962   17,892  
Increase (Decrease) in Shareholders' Equity                          
Contributions from noncontrolling interests 198                     198  
Net transfers to parent (29,584)           (28,342)         (1,242)  
Distributions to noncontrolling interests (15,414)                     (15,414)  
Net (loss) income of unconsolidated joint ventures $ (9,084)                 (8,951)   (133)  
Ending Balance (in shares) at Dec. 31, 2020 32,557,303     32,557,303                  
Ending balance at Dec. 31, 2020 $ 529,486     $ 3     496,171     32,011   1,301  
Increase (Decrease) in Shareholders' Equity                          
Recapitalization transaction, net of fees and deferred taxes (in shares)       13,673,722                  
Recapitalization transaction, net of fees and deferred taxes 33,368     $ 2     33,366            
Vesting of restricted stock units (in shares)       50,066                  
Stock-based compensation expense 5,808           5,808            
Net (loss) income of unconsolidated joint ventures $ 52,735                 52,786   (51)  
Ending Balance (in shares) at Dec. 31, 2021 46,281,091     46,281,091                  
Ending balance at Dec. 31, 2021 $ 621,397     $ 5     $ 535,345     $ 84,797   $ 1,250